Halitosis occurrence due to systemic disease and medication
1 Department of Oral Biology, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia.
2 Faculty of Dental Medicine, Airlangga University, Surabaya, Indonesia.
Research Article
World Journal of Advanced Research and Reviews, 2024, 22(02), 827–831
Publication history:
Received on 02 April 2024; revised on 12 May 2024; accepted on 14 May 2024
Abstract:
Background: Halitosis, a term originating from "halitisus" and the Greek suffix "osis," refers to malodorous breath. It is a common problem impacting individuals globally, with prevalence estimates ranging from 24% to 65%. Dental issues, dry mouth, infections, medications, and systemic diseases can contribute to halitosis. Notably, systemic conditions like kidney and liver diseases, diabetes, respiratory infections, and gastritis can produce distinct odors in the mouth. The management of halitosis focuses on identifying and addressing underlying causes, with intraoral interventions like oral hygiene measures and extraoral treatments such as medical management based on the etiology.
Objectives: To review and clarify association between halitosis with systemic diseases and medication.
Conclusion: This study reveals a notable correlation between halitosis and systemic diseases or medication. Halitosis, a common occurrence influenced by various factors, appears to have a strong association with systemic ailments and medication usage.
Keywords:
Halitosis; Systemic Disease; Medication; Public Health; Health Risk
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0